Chemical Compound
idarubicin hydrochloride
CAS Registry Number
57852-57-0
Primary Record
idarubicin hydrochloride
- In stock
- 9,621 g
- Purity
- 99.8 %
- CAS
- 57852-57-0
Compound Identifiers & Properties
- CAS
- 57852-57-0
- PubChem CID
- 636362
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl
- Canonical SMILES
- CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl
Names & Synonyms
- idarubicin hydrochloride
- Idarubicin Hcl
- Idamycin
- Zavedos
- 57852-57-0
- Idamycin PFS
- 4-Demethoxydaunorubicin
- IDARUBICIN
- Idarubicinhydrochloride
- Idarubicin (hydrochloride)
- Idamycin (TN)
- 5VV3MDU5IE
- IMI 30
- Idarubicin hydrochloride PFS
- UNII-5VV3MDU5IE
- RefChem:56927
- Idarubicin hydrochloride?
- AC1LCS3T
- Hydrochloride, Idarubicin
- IMI-30
- 4-Demethoxydaunorubicin hydrochloride
- DTXSID0047797
- MLS001401448
- SCHEMBL4838
- C26H28ClNO9
- IMI30
- C26H27NO9.ClH
- C26H27NO9.HCl
- DTXCID0027775
- MLS000759470
- MFCD00897212
- orb1301162
- CHEMBL1200976
- NSC-256439
- SCHEMBL29367370
- CHEBI:31686
- EINECS 260-990-7
- 4-demethoxy-daunomycihydrochloride
- JVHPTYWUBOQMBP-RVFAQHLVSA-N
- C26-H27-N-O9.Cl-H
- CPD000466355
- GLXC-07976
- KUC110342C
- EX-A1148
- Tox21_111236
- CID636362
- HY-17381R
- IDARUBICIN HYDROCHLORIDE [MI]
- Idarubicin hydrochloride [USAN:INN]
- NSC256439
- s1228
- Idarubicin hydrochloride (JP18/USP)
- IDARUBICIN HYDROCHLORIDE [JAN]
- Idarubicin hydrochloride [USAN:USP:INN]
- SMR000466355
- AKOS025402118
- Idarubicin (hydrochloride) (Standard)
- Tox21_111236_1
- AC-5255
- ACN-036869
- CCG-100886
- CS-1061
- EBC-101076
- FI24535
- IDARUBICIN HYDROCHLORIDE [USAN]
- NC00136
- NSC 256439
- Daunomycin, 4-demethoxy-, hydrochloride
- IDARUBICIN HYDROCHLORIDE [MART.]
- IDARUBICIN HYDROCHLORIDE [VANDF]
- IDARUBICIN HYDROCHLORIDE [USP-RS]
- IDARUBICIN HYDROCHLORIDE [WHO-DD]
- NCGC00093976-03
- NCGC00093976-08
- AS-75944
- HY-17381
- SAM001246676
- SC-25438
- KSC-230-185-1
- CAS-57852-57-0
- Idarubicin Hydrochloride (1mg/mL in DMSO)
- Idarubicin Hydrochloride (1 mg/mL in DMSO)
- NS00087283
- Idarubicin Hydrochloride (10 mg/mL in DMSO)
- IDARUBICIN HYDROCHLORIDE [ORANGE BOOK]
- A10465
- D01747
- IDARUBICIN HYDROCHLORIDE [USP MONOGRAPH]
- W-5198
- 33820-EP2275420A1
- 33820-EP2295055A2
- 33820-EP2295416A2
- 33820-EP2298748A2
- 33820-EP2298764A1
- 33820-EP2298765A1
- 33820-EP2298768A1
- 33820-EP2305642A2
- 33820-EP2311453A1
- 852I570
- A831635
- SR-01000075934
- SR-01000075934-5
- Q27262943
- (7S,9S)-9-acetyl-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
- B0084-094874
- (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
- (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside--hydrogen chloride (1/1)
- (2S,4S)-2-Acetyl-4-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
- (7S,9S)-9-acetyl-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
- (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Hydrochloride (1:1); 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S,9S)- (9CI); 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S-cis)-; 4-DMD HCl; 4-Demethoxydaunorubicin hydrochloride; Idamycin; Idarubicin hydrochloride; NSC 256439; Zavedos
- (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione Hydrochloride
- (7S-cis)-9-Acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride
- (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione hydrochloride
- (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione hydrochloride
- (7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride
- (8S,10S)-10-((2R,4S,5S,6S)-4-amino-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yloxy)-8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxytetracene-5,12-dione hydrochloride
- 1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE, HYDROCHLORIDE
- 5,12-Naftacenediona, 9-acetil-7-[(3-amino-2,3,6-trideoxi alfa-L-lixo-hexopiranosil)] oxi-7,8,9,10-tetrahidro-6,9,11-trihidroxi-, clorhidrato (1:1), (7S, 9S)-
- 5,12-NAPHTHACENEDIONE, 9-ACETYL-7-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,9,11-TRIHYDROXYHYDROCHLORIDE, (7S-CIS)-
- 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride, (7S-cis)-
- 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride, (7S-cis)-
- 58957-92-9